Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Proceedings (Baylor University. Medical Center)|May 6, 2022
Meta-analysis of randomized controlled trials on primary ambulatory thromboprophylaxis in patients with ovarian cancer receiving chemotherapyThura Win Htut, Kyaw Zin Thein, Thein Hlaing OoJournal of Immunotherapy and Precision Oncology|June 6, 2022
Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled TrialsThura Win Htut, Myat Min Han, Kyaw Zin TheinJournal of Evidence-Based Medicine|May 20, 2021
Pernicious anemia: Pathophysiology and diagnostic difficultiesThura Win Htut, Kyaw Zin Thein, Thein Hlaing OoTherapeutic Advances in Drug Safety|February 25, 2021
Systematic review of immunosuppressant guidelines in the COVID-19 pandemicFenella Barlow-Pay, Thura Win Htut, Mina Khezrian, et al.Proceedings (Baylor University. Medical Center)|December 31, 2021
Meta-analysis of randomized controlled trials on primary ambulatory thromboprophylaxis in patients with nonpancreatic gastrointestinal cancers receiving chemotherapyThura Win Htut, Kyaw Zin Thein, Donald Paul Quick, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 17, 2022
Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?Thura Win Htut, Kyaw Zin Thein, Kyaw Lwin Aung, et al.Lung|March 20, 2020
Impact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Lung Cancer Receiving ChemotherapyKyaw Zin Thein, Donald Paul Quick, Thura Win Htut, et al.Breast Cancer Research and Treatment|July 11, 2020
Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trialsKyaw Zin Thein, Thura Win Htut, Somedeb Ball, et al.Proceedings (Baylor University. Medical Center)|August 24, 2023
Updated meta-analysis of randomized controlled trials on primary outpatient thromboprophylaxis in patients with gastric and gastroesophageal junction cancers receiving chemotherapyKyaw Zin Thein, Thura Win Htut, Yin Mon Myat, et al.Exploration of Targeted Anti-Tumor Therapy|March 24, 2025
A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximabDaniel Thomas Jones, Hazem Aboaid, Ramaditya Srinivasmurthy, et al.Pageof 2